| Item Type | Name |
|
Concept
|
Biomarkers
|
|
Concept
|
Biomarkers, Tumor
|
|
Academic Article
|
Clinical trials for the antiphospholipid syndrome.
|
|
Academic Article
|
The role of biomarkers in the assessment of lupus.
|
|
Academic Article
|
Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms.
|
|
Academic Article
|
Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus.
|
|
Academic Article
|
Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort.
|
|
Academic Article
|
Dysregulation of the microvasculature in nonlesional non-sun-exposed skin of patients with lupus nephritis.
|
|
Academic Article
|
Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.
|
|
Academic Article
|
Clinical and Serologic Features in Patients With Incomplete Lupus Classification Versus Systemic Lupus Erythematosus Patients and Controls.
|
|
Academic Article
|
Pathways of impending disease flare in African-American systemic lupus erythematosus patients.
|
|
Academic Article
|
Contribution of Socioeconomic Status to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes Among Women With Systemic Lupus Erythematosus.
|
|
Academic Article
|
Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus.
|
|
Academic Article
|
TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus.
|
|
Academic Article
|
Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility.
|
|
Academic Article
|
Proinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flare.
|
|
Academic Article
|
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-a) in patients with systemic lupus erythematosus (ROSE).
|
|
Academic Article
|
Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
|
|
Academic Article
|
The Biomarkers of Lupus Disease Study: A Bold Approach May Mitigate Interference of Background Immunosuppressants in Clinical Trials.
|
|
Academic Article
|
Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus: Results of a Twenty-Four-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase IIb Study.
|
|
Academic Article
|
Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial.
|
|
Academic Article
|
Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort.
|
|
Academic Article
|
Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy.
|
|
Academic Article
|
Low frequency of flares during pregnancy and post-partum in stable lupus patients.
|
|
Academic Article
|
Is individualized medicine on the horizon for lupus?
|
|
Academic Article
|
Biomarkers relevant to atacicept effects in systemic lupus erythematosus patients.
|
|
Academic Article
|
Expression of endothelial protein C receptor in cortical peritubular capillaries associates with a poor clinical response in lupus nephritis.
|
|
Academic Article
|
Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity.
|
|
Academic Article
|
Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity.
|
|
Academic Article
|
Kidney Outcomes and Risk Factors for Nephritis (Flare/De Novo) in a Multiethnic Cohort of Pregnant Patients with Lupus.
|
|
Academic Article
|
Identification of biomarkers of response to abatacept in patients with SLE using deconvolution of whole blood transcriptomic data from a phase IIb clinical trial.
|
|
Academic Article
|
Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study.
|
|
Academic Article
|
Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
|
|
Academic Article
|
Safety and clinical activity of atacicept in the long-term extension of the phase 2b ADDRESS II study in systemic lupus erythematosus.
|
|
Academic Article
|
Immune Response to Enterococcus gallinarum in Lupus Patients Is Associated With a Subset of Lupus-Associated Autoantibodies.
|
|
Academic Article
|
Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials.
|